CBN Friday Special丨A shot in the arm: Awareness raised of HPV vaccination yet supply faces shortage

China has approved the production of the first domestically made vaccine against HPV at the end of 2019, before which the high prices and limited supply of imported vaccines remained a burden for many in the country. China has become the third country globally to achieve an independent cervical cancer vaccine supply. In terms of safety and efficiency, the effects of domestic vaccines are comparable to imported ones, but they cost much less.

 

https://m.21jingji.com/article/20220408/herald/885478b7987fa746a1b29048a3974c99.html